Key Points
- Insider purchase: Croda International insider Steve Foots bought 5 shares at GBX 3,292 each, a transaction worth £164.60. He also purchased 5 shares in both June and July.
- Stock performance: Croda opened at GBX 3,274, with a £4.56 billion market capitalization and a share price near its 12-month high of GBX 3,352.
- Analyst outlook: Analysts maintain a “Moderate Buy” consensus, with three Buy ratings and two Holds and an average price target of GBX 3,390.
Croda International Plc (LON:CRDA - Get Free Report) insider Steve Foots purchased 5 shares of the company's stock in a transaction dated Monday, August 10th. The shares were acquired at an average cost of GBX 3,292 per share, with a total value of £164.60.
Steve Foots also recently made the following trade(s):
- On Friday, July 10th, Steve Foots acquired 5 shares of Croda International stock. The stock was acquired at an average cost of GBX 2,859 per share, for a total transaction of £142.95.
- On Wednesday, June 10th, Steve Foots acquired 5 shares of Croda International stock. The stock was acquired at an average cost of GBX 2,965 per share, for a total transaction of £148.25.
Croda International Stock Performance
LON CRDA opened at GBX 3,274 on Wednesday. The company has a market capitalization of £4.56 billion, a price-to-earnings ratio of 57.54, a PEG ratio of 1.40 and a beta of 0.92. The company has a quick ratio of 2.25, a current ratio of 2.57 and a debt-to-equity ratio of 36.06. Croda International Plc has a twelve month low of GBX 2,426.77 and a twelve month high of GBX 3,352. The stock has a fifty day simple moving average of GBX 3,046.90 and a 200 day simple moving average of GBX 2,939.20.
Croda International (LON:CRDA - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported GBX 72.20 EPS for the quarter. Croda International had a return on equity of 3.65% and a net margin of 4.61%. Sell-side analysts expect that Croda International Plc will post 181.8307268 EPS for the current year.
Analyst Ratings Changes
A number of equities analysts recently commented on CRDA shares. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 3,300 price objective on shares of Croda International in a research note on Wednesday, July 29th. Berenberg Bank restated a "buy" rating and set a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Citigroup boosted their price target on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the stock a "neutral" rating in a research report on Wednesday, July 29th. Finally, Jefferies Financial Group reaffirmed a "buy" rating and issued a GBX 3,500 price objective on shares of Croda International in a research note on Wednesday, July 29th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Croda International presently has a consensus rating of "Moderate Buy" and an average target price of GBX 3,390.
Read Our Latest Analysis on CRDA
About Croda International
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
